Injectable Gamboge-Based In Situ Gel for Sustained Delivery of Imatinib Mesylate

Injectable Gamboge-Based In Situ Gel for Sustained Delivery of Imatinib Mesylate

The aim of this study was to prepare and characterize the imatinib mesylate (IM)-loaded gamboge-based ISG system for local administration of an anticancer agent against colorectal carcinoma. The ISG formulations were prepared in dimethyl sulfoxide (DMSO) and <i>N</i>-methyl-2-pyrrolidone...

Full description

Bibliographic Details
Main Authors: Kritamorn Jitrangsri, Ei Mon Khaing, Torsak Intaraphairot, Thawatchai Phaechamud, Jongjan Mahadlek
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Gels
Subjects:
gamboge
gambogic acid
imatinib mesylate
in situ gel
cytotoxicity
Online Access:https://www.mdpi.com/2310-2861/9/9/737

Internet

https://www.mdpi.com/2310-2861/9/9/737

Similar Items